Hepatitis C
📧 Sign up to get email alerts when something new happens for Hepatitis C.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2020-08-27FDA Approved: SOVALDI — Supplemental Application (Gilead Sciences, Inc.)
FDA approved a supplemental application for Sovaldi (sofosbuvir) from Gilead Sciences, Inc. The approval updates the product’s labeling/indi…
-
FDA approval · 2020-04-10FDA Approved: MAVYRET — Supplemental Application (AbbVie Inc.)
The FDA approved a supplemental application for MAVYRET (glecaprevir and pibrentasvir) from AbbVie.
-
FDA approval · 2020-03-19FDA Approved: EPCLUSA — Supplemental Application (Gilead Sciences, Inc.)
FDA approved a supplemental application for EPCLUSA (velpatasvir/sofosbuvir) from Gilead Sciences.
-
FDA approval · 2020-03-05FDA Approved: LEDIPASVIR AND SOFOSBUVIR — Supplemental Application (Asegua Therapeutics LLC)
The FDA approved a supplemental application for Ledipasvir and Sofosbuvir submitted by Asegua Therapeutics LLC.
-
FDA approval · 2020-03-05FDA Approved: SOVALDI — Supplemental Application (Gilead Sciences, Inc.)
FDA approved a supplemental application for Sovaldi (sofosbuvir) submitted by Gilead Sciences, Inc.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2019-12-11FDA Approved: ZEPATIER — Supplemental Application (Merck Sharp & Dohme LLC)
FDA approved a supplemental application for ZEPATIER (elbasvir and grazoprevir) submitted by Merck Sharp & Dohme LLC.
-
FDA approval · 2019-12-04FDA Approved: HARVONI — Supplemental Application (Gilead Sciences, Inc)
FDA approved a supplemental application for HARVONI (ledipasvir/sofosbuvir) submitted by Gilead Sciences, Inc., resulting in changes to the …
-
FDA approval · 2019-12-04FDA Approved: SOVALDI — Supplemental Application (Gilead Sciences, Inc.)
The FDA approved a supplemental application for Sovaldi (sofosbuvir) submitted by Gilead Sciences, Inc., resulting in updated labeling.
-
FDA approval · 2019-11-15FDA Approved: LEDIPASVIR AND SOFOSBUVIR — Supplemental Application (Asegua Therapeutics LLC)
FDA approved a supplemental application for Ledipasvir and Sofosbuvir (Asegua Therapeutics LLC).
-
FDA approval · 2019-11-15FDA Approved: EPCLUSA — Supplemental Application (Gilead Sciences, Inc.)
The FDA approved a supplemental application for Epclusa (velpatasvir/sofosbuvir) submitted by Gilead Sciences, Inc.
-
FDA approval · 2019-11-15FDA Approved: VOSEVI — Supplemental Application (Gilead Sciences, Inc.)
The FDA approved a supplemental application for VOSEVI (sofosbuvir/velpatasvir/voxilaprevir) from Gilead Sciences.
-
FDA approval · 2019-11-15FDA Approved: HARVONI — Supplemental Application (Gilead Sciences, Inc)
FDA approved a supplemental application for HARVONI (ledipasvir and sofosbuvir) submitted by Gilead Sciences, Inc.
-
FDA approval · 2019-09-27FDA Approved: VOSEVI — Supplemental Application (Gilead Sciences, Inc.)
The FDA approved a supplemental application for VOSEVI (sofosbuvir, velpatasvir, and voxilaprevir) from Gilead Sciences, Inc. VOSEVI is a fi…
-
FDA approval · 2019-09-19FDA Approved: LEDIPASVIR AND SOFOSBUVIR — Supplemental Application (Asegua Therapeutics LLC)
The FDA approved a supplemental application for Ledipasvir and Sofosbuvir submitted by Asegua Therapeutics LLC, resulting in an approved mod…
-
FDA approval · 2019-09-19FDA Approved: SOVALDI — Supplemental Application (Gilead Sciences, Inc.)
FDA approved a supplemental application for Sovaldi (sofosbuvir) from Gilead Sciences, Inc., updating the drug's labeling.
-
FDA approval · 2019-09-19FDA Approved: EPCLUSA — Supplemental Application (Gilead Sciences, Inc.)
FDA approved a supplemental application for Epclusa (velpatasvir/sofosbuvir) submitted by Gilead Sciences, Inc. The approval updates the lab…
-
FDA approval · 2019-09-19FDA Approved: HARVONI — Supplemental Application (Gilead Sciences, Inc)
The FDA approved a supplemental application for HARVONI (ledipasvir/sofosbuvir) from Gilead Sciences.
-
FDA approval · 2019-08-28FDA Approved: SOVALDI — Original Application (Gilead Sciences, Inc.)
The FDA approved Sovaldi (sofosbuvir) from Gilead as the original application for the treatment of chronic hepatitis C virus infection in ad…
-
FDA approval · 2019-08-28FDA Approved: HARVONI — Original Application (Gilead Sciences, Inc)
The FDA approved Harvoni (ledipasvir and sofosbuvir) from Gilead as an original application for the treatment of hepatitis C virus infection…
-
FDA approval · 2019-08-28FDA Approved: SOVALDI — Supplemental Application (Gilead Sciences, Inc.)
The FDA approved a supplemental application for Sovaldi (sofosbuvir) from Gilead Sciences, Inc. The action updates the drug’s labeling and/o…
-
FDA approval · 2019-08-28FDA Approved: LEDIPASVIR AND SOFOSBUVIR — Supplemental Application (Asegua Therapeutics LLC)
FDA approves a supplemental application for Ledipasvir and Sofosbuvir by Asegua Therapeutics LLC. The change pertains to the Ledipasvir and …
-
FDA approval · 2019-04-30FDA Approved: MAVYRET — Supplemental Application (AbbVie Inc.)
FDA approved a supplemental application for MAVYRET (glecaprevir and pibrentasvir) from AbbVie.
-
FDA approval · 2018-10-23FDA Approved: SOVALDI — Supplemental Application (Gilead Sciences, Inc.)
The FDA approved a supplemental application for Sovaldi (sofosbuvir) submitted by Gilead Sciences, Inc. The approval updates the product lab…
-
FDA approval · 2018-08-06FDA Approved: MAVYRET — Supplemental Application (AbbVie Inc.)
FDA approved a supplemental application for MAVYRET (glecaprevir and pibrentasvir) submitted by AbbVie. The action approves a supplemental c…
-
FDA approval · 2018-06-28FDA Approved: ZEPATIER — Supplemental Application (Merck Sharp & Dohme LLC)
The FDA approved a supplemental application for ZEPATIER (elbasvir and grazoprevir) from Merck Sharp & Dohme LLC.